9th of July, 2024
Olpha will already be offering four new medicines on EU markets this year; next year their number will grow to at least 20
Read
Olpha will already be offering four new medicines on EU markets this year; next year their number will grow to at least 20
9th of July, 2024
By the end of this year, the leading Latvian pharmaceutical company and drug manufacturer JSC Olpha will offer four different new medicines in several European Union (EU) countries and the United Kingdom, which have passed the registration process and also met other regulatory requirements. The new drugs are intended for the treatment of urological, oncological and cardiovascular diseases. At least 18 new patent-free (generic) medicines are expected to enter the EU markets next year.
Read article
